Abstract
Background Hyperthyroidism is associated with alterations in metabolism that currently are only partially understood. The objective of the study was to investigate changes in metabolism associated with reinstatement of euthyroidism in Swedish patients. Methods We profiled 80 metabolites in plasma from 10 subjects with Graves' disease at baseline and after 9 and 15 month of treatment to reinstate euthyroidism. Thyroid parameters, thyroid stimulating hormone (TSH), TSH receptor antibodies, free T3 and T4 were followed. Main findings were validated in plasma from 20 subjects with Graves' disease at baseline and at 3, 6, and 9 month. The study was conducted at the endocrinological clinic in Malmö, Sweden. Results Euthyriodism was reinstated at 3 month and thyroid status did not change further during the 15 month follow-up. This was paralleled by altered levels of 9 out of 19 detected acylcarnitines (p<0.05 after adjustment for multiple testing). Levels of short-chain acylcarnitines were decreased, levels of intermediate-chain acylcarnitines elevated and long-chain acylcarnitines unaltered. Conclusions Graves' disease and treatment of the disease is associated with pronounced acyl chain-length dependent alterations in acylcarnitine levels. These changes may be impacted by ethnicity and or dietary differences.

This publication has 43 references indexed in Scilit: